Published in AIDS Weekly, October 18th, 1999
Rather, antiretroviral treatment drives HIV down to stable levels, which vary with the efficacy of the drug regimen.
One implication of the new model could be a more favorable interpretation of some treatment outcomes once described as failures, according to a report in the October 1999 issue of Nature Medicine.
"Our interpretation is fundamentally different than the currently accepted one," said William E. Paul, MD, chief of the Laboratory of Immunology at the U.S. National Institute of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.